Norges Bank’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-33,459,884
Closed -$6.92B 710
2025
Q4
$6.92B Buy
+33,459,884
New +$6.62B 0.74% 14
2025
Q3
Sell
-31,929,124
Closed -$4.88B 793
2025
Q2
$4.88B Buy
31,929,124
+1,117,802
+4% +$172M 0.61% 23
2025
Q1
$5.11B Buy
30,811,322
+455,650
+2% +$71.3M 0.72% 20
2024
Q4
$4.39B Buy
30,355,672
+1,315,500
+5% +$204M 0.58% 25
2024
Q3
$4.71B Sell
29,040,172
-52,197
-0.2% -$8.32M 0.66% 21
2024
Q2
$4.25B Buy
29,092,369
+603,587
+2% +$89.8M 0.64% 22
2024
Q1
$4.51B Buy
28,488,782
+2,511,740
+10% +$400M 0.71% 20
2023
Q4
$4.07B Buy
25,977,042
+2,388,482
+10% +$366M 0.71% 18
2023
Q3
$3.67B Sell
23,588,560
-4,261,363
-15% -$703M 0.75% 17
2023
Q2
$4.61B Buy
27,849,923
+3,322
+0% +$536K 0.91% 12
2023
Q1
$4.32B Buy
27,846,601
+1,753,203
+7% +$283M 0.94% 11
2022
Q4
$4.61B Buy
26,093,398
+1,512,633
+6% +$261M 1.11% 7
2022
Q3
$4.02B Buy
24,580,765
+782,418
+3% +$132M 1.07% 9
2022
Q2
$4.22B Sell
23,798,347
-685,675
-3% -$122M 1.09% 8
2022
Q1
$4.34B Buy
24,484,022
+90,911
+0.4% +$15.5M 0.95% 10
2021
Q4
$4.17B Sell
24,393,111
-551,739
-2% -$90.3M 0.86% 10
2021
Q3
$4.03B Sell
24,944,850
-863,600
-3% -$147M 0.89% 9
2021
Q2
$4.25B Sell
25,808,450
-1,169,667
-4% -$194M 0.92% 9
2021
Q1
$4.43B Sell
26,978,117
-792,669
-3% -$128M 1.02% 7
2020
Q4
$4.37B Sell
27,770,786
-454,315
-2% -$67M 1.02% 8
2020
Q3
$4.2B Sell
28,225,101
-46,065
-0.2% -$6.82M 1.12% 7
2020
Q2
$3.98B Sell
28,271,166
-172,927
-0.6% -$25.2M 1.14% 7
2020
Q1
$3.73B Buy
28,444,093
+68,779
+0.2% +$9.76M 1.33% 7
2019
Q4
$4.14B Buy
28,375,314
+18,223
+0.1% +$2.47M 1.16% 7
2019
Q3
$3.67B Hold
28,357,091
1.12% 6
2019
Q2
$3.95B Buy
28,357,091
+199,936
+0.7% +$27.7M 1.22% 6
2019
Q1
$3.94B Buy
28,157,155
+1,150,562
+4% +$154M 1.27% 6
2018
Q4
$3.49B Buy
27,006,593
+1,059,857
+4% +$148M 1.3% 5
2018
Q3
$3.59B Buy
25,946,736
+86,016
+0.3% +$11.4M 1.16% 6
2018
Q2
$3.14B Buy
25,860,720
+105,403
+0.4% +$13.2M 1.08% 9
2018
Q1
$3.3B Buy
25,755,317
+220,845
+0.9% +$29.9M 1.19% 8
2017
Q4
$3.57B Sell
25,534,472
-230,213
-0.9% -$32.1M 1.28% 6
2017
Q3
$3.35B Sell
25,764,685
-110,189
-0.4% -$14.6M 1.27% 5
2017
Q2
$3.42B Sell
25,874,874
-1,110,481
-4% -$142M 1.36% 4
2017
Q1
$3.36B Sell
26,985,355
-966,399
-3% -$115M 1.38% 3
2016
Q4
$3.22B Buy
27,951,754
+895,338
+3% +$103M 1.41% 5
2016
Q3
$3.05B Buy
27,056,416
+160,867
+0.6% +$19.5M 1.44% 3
2016
Q2
$3.26B Buy
26,895,549
+965,348
+4% +$110M 1.55% 4
2016
Q1
$2.81B Buy
25,930,201
+1,274,044
+5% +$132M 1.38% 5
2015
Q4
$2.53B Buy
24,656,157
+789,653
+3% +$79.4M 1.26% 6
2015
Q3
$2.23B Buy
23,866,504
+1,383,083
+6% +$134M 1.17% 7
2015
Q2
$2.19B Buy
22,483,421
+347,989
+2% +$34.8M 1.1% 7
2015
Q1
$2.23B Buy
22,135,432
+544,815
+3% +$55.4M 1.09% 8
2014
Q4
$2.26B Buy
21,590,617
+780,650
+4% +$82.3M 1.15% 6
2014
Q3
$2.22B Sell
20,809,967
-20,559,041
-50% -$2.13B 1.2% 6
2014
Q2
$4.33B Buy
41,369,008
+20,684,504
+100% +$2.09B 1.17% 7
2014
Q1
$2.03B Buy
20,684,504
+10,825
+0.1% +$1M 1.15% 7
2013
Q4
$1.89B Sell
20,673,679
-1,443,216
-7% -$133M 1.09% 9
2013
Q3
$1.92B Hold
22,116,895
1.12% 8
2013
Q2
$1.9B Buy
+22,116,895
New +$1.88B 1.18% 8

Other funds holding JNJ

Norges Bank's JNJ Position: Q1 2026 in Review

Norges Bank sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 33,459,884 shares — an estimated $6.92B sold.

Norges Bank first reported a position in JNJ in Q2 2013 and held it in 50 quarters. The position peaked at $6.92B in Q4 2025. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Norges Bank reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Norges Bank sold 33,459,884 Johnson & Johnson shares in Q1 2026, an estimated $6.92B.
  • Norges Bank first reported a position in Johnson & Johnson in Q2 2013 and held it in 50 quarters.
  • Norges Bank's Johnson & Johnson position peaked at $6.92B in Q4 2025.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.